Fathom Therapeutics
Also known as Atommap, Atommap Corp.
Simulates protein motion at atomic resolution with quantum chemistry and AI in its Microcosmos engine, and designs small molecules, including degraders, against that dynamic behaviour.
Money and evidence
No research by this company is on the record yet.
Rounds and research, on one timeline
- 2026-04-27Series ARound
$47M
For: scaling its lab-in-the-loop capabilities and expanding internal discovery programmes
Wet labModels and platform
Oversubscribed; the release names other investors without listing them ("among others"). Chemistry is the venture firm co-founded by Ethan Kurzweil.
Lead · Sutter Hill VenturesChemistryAlexandria Venture InvestmentsNY Ventures (Empire State Development)
On the deal: Ethan Kurzweil (Co-Founder and Managing Partner; spoke for the firm in the announcement, Chemistry); Keith Loebner (Managing Director; spoke for the lead in the announcement, Sutter Hill Ventures)
Research entries are the timeline's graded entries that name this company. A level grades one claim, not the company, and a blank can mean the record has not caught up rather than that nothing was published.
Its investors also backed
Other companies on this page whose rounds name the same investor.
- Alexandria Venture InvestmentsIambic Therapeutics, BigHat Biosciences, Terray Therapeutics, Matchpoint Therapeutics